Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples

Genetics in Medicine

Volumn 4, Issue 4, 2002, Pages 289-296

  Strom, Charles M ^a   Huang, Donghui ^a   Buller, Arlene ^a   Redman, Joy ^a   Crossley, Beryl ^a   Anderson, Ben ^a   Entwistle, Tom ^a   Sun, Weimin ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Allele frequencies; Carrier screening; Cystic fibrosis; Population screening

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE CARRIER; DNA DETERMINATION; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL EDUCATION; ALLELE; ANALYTICAL EQUIPMENT; EVALUATION; FEMALE; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE DETECTION; MALE; METHODOLOGY; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

ALLELES; CYSTIC FIBROSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MASS SCREENING; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY; PRENATAL DIAGNOSIS; REAGENT KITS, DIAGNOSTIC;

EID: 0036654506     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-200207000-00007     Document Type: Article

References (12)

1. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson M, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
2. American College of Obstetrics and Gynecology, and American College of Medical Genetics. Preconception and prenatal carrier screening for Cystic Fibrosis. Clinical and laboratory guidelines. Washington, DC: American College of Obstetrics and Gynecology, 2001.
3. Hospital for Sick Children, Toronto, Cystic Fibrosis Mutation Database, http://www.genet.sickkids.on.ca/cftr/
4. Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded pan-ethnic panel. Genet Med 2001;3:168-176.
5. Rohlfs EM, Zhou Z, Sugarman EA, Heim EI, Pace RG, Knowles MR, Silverman LM, Allitto BA. The I148T CFTR mutation confers a variable phenotype and occurs on multiple haplotypes. Paper presented at the 2001 Annual Meeting of the American Association of Human Genetics [abstract 2600]. Abstract appears in Am J Hum Genet Suppl 2001;69.
6. Rave-Harel N, Kerem E, Nissim-Rafinia M, Madjar I, Goshen R, Augarten A, Rahat A, Hurwitz A, Darvasi A, Kerem B. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet 1997;60:87-94.
7. Chu CS, Trapnell BC, Curristan S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane regulator mRNA. Nat Genet 1993; 3:151-156.
8. Niksik M, Romano M, Buratti E, Pagnini F, Baralle FE. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet 1999;8:2339-2349.
9. Chillon M, Casals T, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Ferec C, Estivill X. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332:1474-1480.
10. Costes B, Giroden E, Ghanem N, Fiori E, Jardin A, Souffir JC, Goosens M. Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital absence of the vas deferens. Eur J Hum Genet 1995;3:285-293.
11. Palomaki GE, Haddow JE, Bradley LA, FitzSimmons SC. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians. Genet Med 2002; 4:90-94.
12. Le Marechal C, Audrezet MP, Quere I, Raguenes O, Langonne S, Ferec C. Complete and rapid scanning of the cystic fibrosis transmembrane regulator (CFTR) by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counseling. Hum Genet 2001;108:290-298.